Based on the analysis of Aptorum Group's profitability, liquidity, and operating efficiency, Aptorum Group Ltd is not in a good financial situation at this time. It has a very high odds of going through financial crisis in April. At this time, Aptorum Group's Short and Long Term Debt Total is very stable compared to the past year. As of the 2nd of March 2025, Property Plant And Equipment Net is likely to grow to about 3 M, while Total Stockholder Equity is likely to drop about 21.1 M. Key indicators impacting Aptorum Group's financial strength include:
Investors should never underestimate Aptorum Group's ability to pay suppliers on time, ensure interest payments are not accumulating, and correctly time where and how to reinvest extra cash. Individual investors need to monitor Aptorum Group's cash flow, debt, and profitability to make informed and accurate decisions about investing in Aptorum Group Ltd.
Net Income
(2.67 Million)
Aptorum
Select Account or Indicator
Market Cap
Enterprise Value
Price To Sales Ratio
Ptb Ratio
Days Sales Outstanding
Book Value Per Share
Free Cash Flow Yield
Operating Cash Flow Per Share
Stock Based Compensation To Revenue
Capex To Depreciation
Pb Ratio
Ev To Sales
Free Cash Flow Per Share
Roic
Inventory Turnover
Net Income Per Share
Days Of Inventory On Hand
Sales General And Administrative To Revenue
Average Inventory
Research And Ddevelopement To Revenue
Capex To Revenue
Cash Per Share
Pocfratio
Interest Coverage
Capex To Operating Cash Flow
Pfcf Ratio
Income Quality
Roe
Ev To Operating Cash Flow
Pe Ratio
Return On Tangible Assets
Ev To Free Cash Flow
Earnings Yield
Intangibles To Total Assets
Net Debt To E B I T D A
Current Ratio
Tangible Book Value Per Share
Receivables Turnover
Graham Number
Shareholders Equity Per Share
Debt To Equity
Capex Per Share
Graham Net Net
Revenue Per Share
Interest Debt Per Share
Debt To Assets
Enterprise Value Over E B I T D A
Short Term Coverage Ratios
Price Earnings Ratio
Operating Cycle
Price Book Value Ratio
Price Earnings To Growth Ratio
Price To Operating Cash Flows Ratio
Price To Free Cash Flows Ratio
Pretax Profit Margin
Ebt Per Ebit
Operating Profit Margin
Effective Tax Rate
Company Equity Multiplier
Long Term Debt To Capitalization
Total Debt To Capitalization
Return On Capital Employed
Debt Equity Ratio
Ebit Per Revenue
Quick Ratio
Dividend Paid And Capex Coverage Ratio
Net Income Per E B T
Cash Ratio
Cash Conversion Cycle
Operating Cash Flow Sales Ratio
Days Of Inventory Outstanding
Days Of Sales Outstanding
Free Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage Ratios
Price To Book Ratio
Fixed Asset Turnover
Capital Expenditure Coverage Ratio
Price Cash Flow Ratio
Enterprise Value Multiple
Debt Ratio
Cash Flow To Debt Ratio
Price Sales Ratio
Return On Assets
Asset Turnover
Net Profit Margin
Gross Profit Margin
Price Fair Value
Return On Equity
Change To Inventory
Investments
Change In Cash
Net Borrowings
Total Cashflows From Investing Activities
Other Cashflows From Financing Activities
Depreciation
Capital Expenditures
Total Cash From Operating Activities
Change To Account Receivables
Change To Operating Activities
Net Income
Total Cash From Financing Activities
End Period Cash Flow
Other Cashflows From Investing Activities
Change To Netincome
Change To Liabilities
Sale Purchase Of Stock
Free Cash Flow
Change In Working Capital
Begin Period Cash Flow
Other Non Cash Items
Issuance Of Capital Stock
Stock Based Compensation
Total Assets
Other Current Liab
Total Current Liabilities
Total Stockholder Equity
Net Tangible Assets
Retained Earnings
Accounts Payable
Cash
Net Receivables
Other Stockholder Equity
Total Liab
Long Term Investments
Total Current Assets
Common Stock
Short Long Term Debt Total
Property Plant And Equipment Net
Net Debt
Non Current Assets Total
Non Currrent Assets Other
Other Assets
Cash And Short Term Investments
Common Stock Total Equity
Common Stock Shares Outstanding
Short Term Investments
Liabilities And Stockholders Equity
Non Current Liabilities Total
Capital Surpluse
Other Current Assets
Net Invested Capital
Property Plant And Equipment Gross
Short Long Term Debt
Accumulated Other Comprehensive Income
Net Working Capital
Short Term Debt
Intangible Assets
Property Plant Equipment
Capital Lease Obligations
Inventory
Capital Stock
Long Term Debt
Interest Expense
Selling General Administrative
Total Revenue
Gross Profit
Other Operating Expenses
Operating Income
Net Income From Continuing Ops
Ebit
Research Development
Cost Of Revenue
Total Operating Expenses
Income Before Tax
Total Other Income Expense Net
Net Income Applicable To Common Shares
Income Tax Expense
Minority Interest
Interest Income
Net Interest Income
Depreciation And Amortization
Ebitda
Reconciled Depreciation
Selling And Marketing Expenses
Probability Of Bankruptcy
Understanding current and past Aptorum Group Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Aptorum Group's financial statements are interrelated, with each one affecting the others. For example, an increase in Aptorum Group's assets may result in an increase in income on the income statement.
Aptorum Group competes with Surrozen, Unicycive Therapeutics, Armata Pharmaceuticals, AIM ImmunoTech, and Biocardia. Aptorum Group Limited, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products for the treatment of infectious diseases and cancer. Aptorum Group Limited was incorporated in 2010 and is headquartered in London, the United Kingdom. Aptorum operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 26 people.
Specialization
Health Care, Pharmaceuticals, Biotechnology & Life Sciences
Comparative valuation techniques use various fundamental indicators to help in determining Aptorum Group's current stock value. Our valuation model uses many indicators to compare Aptorum Group value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Aptorum Group competition to find correlations between indicators driving Aptorum Group's intrinsic value. More Info.
Aptorum Group Ltd is rated second in return on equity category among its peers. It is rated fourth in return on asset category among its peers . At this time, Aptorum Group's Return On Equity is very stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Aptorum Group by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.
Aptorum Group Systematic Risk
Aptorum Group's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Aptorum Group volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was thirty with a total number of output elements of thirty-one. The Beta measures systematic risk based on how returns on Aptorum Group correlated with the market. If Beta is less than 0 Aptorum Group generally moves in the opposite direction as compared to the market. If Aptorum Group Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Aptorum Group is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Aptorum Group is generally in the same direction as the market. If Beta > 1 Aptorum Group moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in Aptorum Group Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Aptorum Group's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Aptorum Group growth as a starting point in their analysis.
Along with financial statement analysis, the daily predictive indicators of Aptorum Group help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Aptorum Group Ltd. We use our internally-developed statistical techniques to arrive at the intrinsic value of Aptorum Group Ltd based on widely used predictive technical indicators. In general, we focus on analyzing Aptorum Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Aptorum Group's daily price indicators and compare them against related drivers.
When determining whether Aptorum Group is a strong investment it is important to analyze Aptorum Group's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Aptorum Group's future performance. For an informed investment choice regarding Aptorum Stock, refer to the following important reports:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aptorum Group Ltd. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aptorum Group. If investors know Aptorum will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aptorum Group listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
0.31
Quarterly Revenue Growth
(1.00)
Return On Assets
(0.27)
Return On Equity
(0.03)
The market value of Aptorum Group is measured differently than its book value, which is the value of Aptorum that is recorded on the company's balance sheet. Investors also form their own opinion of Aptorum Group's value that differs from its market value or its book value, called intrinsic value, which is Aptorum Group's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aptorum Group's market value can be influenced by many factors that don't directly affect Aptorum Group's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aptorum Group's value and its price as these two are different measures arrived at by different means. Investors typically determine if Aptorum Group is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aptorum Group's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.